MOH — authorised 15 May 2013
- Marketing authorisation holder: BAYER HLTHCARE
- Status: likely_approved
🇮🇱 Xofigo in Israel
MOH authorised Xofigo on 15 May 2013
Marketing authorisation
Xofigo in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in Israel
Frequently asked questions
Is Xofigo approved in Israel?
Yes. MOH authorised it on 15 May 2013.
Who is the marketing authorisation holder for Xofigo in Israel?
BAYER HLTHCARE holds the Israeli marketing authorisation.